Total Payments
$135,523
2024 Payments
$26,941
Companies
31
Transactions
829
Medicare Patients
4,042
Medicare Billing
$590,446
Payment Breakdown by Category
Other$104,763 (77.3%)
Food & Beverage$15,829 (11.7%)
Consulting$8,355 (6.2%)
Travel$6,380 (4.7%)
Education$195.97 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $104,763 | 52 | 77.3% |
| Food and Beverage | $15,829 | 721 | 11.7% |
| Consulting Fee | $8,355 | 6 | 6.2% |
| Travel and Lodging | $6,380 | 40 | 4.7% |
| Education | $195.97 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $38,601 | 174 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $37,722 | 57 | $0 (2020) |
| GlaxoSmithKline, LLC. | $33,362 | 137 | $0 (2024) |
| PFIZER INC. | $14,931 | 59 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $2,467 | 15 | $0 (2021) |
| CSL Behring | $1,638 | 80 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,047 | 49 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $963.12 | 38 | $0 (2024) |
| Mylan Specialty L.P. | $633.20 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $615.96 | 32 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,941 | 100 | AstraZeneca Pharmaceuticals LP ($25,829) |
| 2023 | $12,518 | 117 | AstraZeneca Pharmaceuticals LP ($5,714) |
| 2022 | $29,561 | 103 | GlaxoSmithKline, LLC. ($22,622) |
| 2021 | $6,137 | 90 | GlaxoSmithKline, LLC. ($4,753) |
| 2020 | $4,668 | 77 | PFIZER INC. ($3,146) |
| 2019 | $9,717 | 113 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,536) |
| 2018 | $23,656 | 133 | Boehringer Ingelheim Pharmaceuticals, Inc. ($10,629) |
| 2017 | $22,324 | 96 | Boehringer Ingelheim Pharmaceuticals, Inc. ($20,539) |
All Payment Transactions
829 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Immunology | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Immunology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Immunology | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $86.55 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $10.72 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 943 | 16,967 | $417,832 | $159,699 |
| 2022 | 10 | 933 | 16,447 | $342,194 | $154,751 |
| 2021 | 16 | 1,334 | 16,173 | $375,427 | $163,089 |
| 2020 | 15 | 832 | 13,439 | $307,730 | $112,907 |
Total Patients
4,042
Total Services
63,026
Medicare Billing
$590,446
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 153 | 6,701 | $172,349 | $71,174 | 41.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 104 | 2,201 | $43,020 | $17,311 | 40.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 91 | 5,622 | $76,722 | $16,461 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 113 | 183 | $26,937 | $15,316 | 56.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 237 | $25,470 | $14,052 | 55.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $16,769 | $8,364 | 49.9% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 72 | 963 | $19,089 | $5,798 | 30.4% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 33 | 766 | $12,843 | $4,929 | 38.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 62 | 92 | $14,676 | $2,334 | 15.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $3,746 | $1,962 | 52.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 15 | 16 | $1,355 | $684.96 | 50.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 15 | 16 | $1,307 | $657.28 | 50.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 67 | $3,551 | $656.97 | 18.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 158 | 6,351 | $127,198 | $70,563 | 55.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 89 | 5,777 | $69,324 | $16,928 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 184 | $22,264 | $15,604 | 70.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 99 | 1,846 | $34,609 | $14,229 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 182 | 254 | $20,955 | $14,051 | 67.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $12,765 | $7,690 | 60.2% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 70 | 913 | $22,825 | $5,785 | 25.3% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 43 | 927 | $12,774 | $5,599 | 43.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 84 | 107 | $17,067 | $2,793 | 16.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $2,413 | $1,508 | 62.5% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 151 | 5,457 | $127,213 | $63,873 | 50.2% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 94 | 6,030 | $72,360 | $18,441 | 25.5% |
About Dr. Michael Wolbert, M.D
Dr. Michael Wolbert, M.D is a Allergy & Immunology healthcare provider based in Midland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1881711778.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Wolbert, M.D has received a total of $135,523 in payments from pharmaceutical and medical device companies, with $26,941 received in 2024. These payments were reported across 829 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($104,763).
As a Medicare-enrolled provider, Wolbert has provided services to 4,042 Medicare beneficiaries, totaling 63,026 services with total Medicare billing of $590,446. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Midland, TX
- Active Since 03/23/2007
- Last Updated 08/11/2021
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1881711778
Products in Payments
- TEZSPIRE (Biological) $36,785
- NUCALA (Biological) $32,731
- SPIRIVA RESPIMAT (Drug) $25,368
- EUCRISA (Drug) $10,857
- STIOLTO RESPIMAT (Drug) $3,413
- XALKORI (Drug) $3,000
- QVAR (Drug) $1,597
- DUPIXENT (Biological) $1,295
- CUVITRU (Biological) $1,019
- Hizentra (Biological) $871.96
- PROAIR (Drug) $749.92
- Haegarda (Biological) $669.70
- XOLAIR (Biological) $600.11
- FASENRA (Drug) $587.88
- SYMBICORT (Drug) $509.10
- Xembify (Biological) $503.51
- TRELEGY ELLIPTA (Drug) $423.55
- ADBRY (Biological) $417.63
- Yupelri (Drug) $359.88
- FASENRA (Biological) $304.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.